BioSerenity is a medical technology company building an integrated neuroscience platform that combines wearable EEG hardware, cloud software, and AI-assisted analytics to support electrophysiological diagnosis and long-term patient monitoring. The platform includes ambulatory EEG systems, easy-to-deploy sensor nets, and digital tools to capture and transmit electrophysiological signals from clinical or home environments.

The company’s solutions span smart medical sensors, cloud-based data platforms, and tele-interpretation services, enabling remote EEG acquisition and analysis workflows tailored to neurology, sleep disorders, and other chronic conditions. Its software suite supports clinical scheduling, signal processing, and collaborative interpretation across distributed care settings.

BioSerenity’s technology is positioned for clinical use by hospitals, sleep centers, and neurologists to improve diagnostic access, reduce barriers to long-term monitoring, and streamline electrophysiological workflows. The company also supports research and pharmaceutical deployments through data acquisition and digital biomarker extraction.